Počet záznamov: 1
Trendy vo farmakoekonomike v kardiológii
SYS 0103161 LBL 00000naa^^22^^^^^^^^450 005 20141128095127.5 100 $a 20141031a2014 m y0sloy0103 ba 101 0-
$a slo $a eng 102 $a SK 200 1-
$a Trendy vo farmakoekonomike v kardiológii $e podľa výstupov 16. kongresu ISPOR v Dubline $f Karolina Hoffmannová 215 $c ilustr., tab. 327 0-
$a Improving adherence to lipid-lowering therapy in a community pharmacy intervention program: a cost-effectiveness analysis / Egter et al. $a What factors predict the decision to treat acute coronary syndrome invasively? Evidence from clinical practice / Fakhouri et al. $a Patient-level costs of cardiovascular events and procedures: how robust is the evidence? / Nicholson et al. $a Application of new french guidelines for economic evaluations: a cost-effectiveness analysis of apixaban in patients with non-valvular atrial fibrillation in France / Durand Zaleski 463 -1
$1 001 sllk_un_cat*0101364 $1 011 $a 1336-7021 $1 200 1 $a Farmakoekonomika a lieková politika $e oficiálny časopis Slovenskej spoločnosti pre farmakoekonomiku $v Roč. 10, č. 2 (2014), s. 41-42 $1 210 $a Nové Mesto nad Váhom $c TISING $d 2014 $1 215 $a s. 2-60 606 1-
$3 sllk_un_auth*d017850 $a farmakoekonomika $x trendy $2 mesh 606 1-
$3 sllk_un_auth*d002318 $a choroby kardiovaskulárne $x ekonomika $2 mesh 606 2-
$3 sllk_un_auth*d017202 $a choroba srdca, ischemická $x ekonomika $2 mesh 606 2-
$3 sllk_un_auth*d019468 $a manažment choroby $2 mesh 606 2-
$3 sllk_un_auth*d000925 $a antikoagulanciá $x ekonomika $2 mesh 610 2-
$a postery 700 -1
$3 sllk_un_auth*0031626 $a Hoffmannová $b Karolina $p AstraZeneca AB, o.z., Bratislava $4 070 712 12
$3 sllk_un_auth*0033579 $a Farmakoekonomika na Slovensku $b Vedecká konferencia SSFE a Kancelárie WHO s medzinárodnou účasťou $d 27. $e Bratislava, Slovensko $f 2014 801 -0
$a SK $b BA006 $c 20141031 $g AACR2
Počet záznamov: 1